Ethyl (2S,3S,4S)-(-)-3-ethyl-2-(N-p-toluenesulfonylindol-3-yl)-
piperidine-4-caboxylate (22a) and Ethyl (2S,3S,4R)-(-)-3-ethyl-
2-(N-p-toluenesulfonylindol-3-yl)-piperidine-4-caboxylate (22b).
To a solution of 21 (924 mg, 1.47 mmol, mixture of diastereomers)
and n-propylamine (1.09 ml, 13.2 mmol) in chloroform (15 ml)
was added lead tetraacetate (2.61 mg, 5.88 mmol) at -50 ◦C. After
the mixture was stirred for 15 min, it was added to an ice-1 N
aqueous NaOH solution. The resulting mixture was filtered and
extracted with chloroform. The organic layers were combined,
washed with H2O, dried over MgSO4, filtered and concentrated
in vacuo to give the crude products of a 3.0 : 1 mixture of C4
stereoisomers. Column chromatography on silica gel (from 0% to
2.8% methanol in chloroform) gave 22a (159 mg, 24%) as a yellow
amorphous solid and 22b (476 mg, 71%) as a yellow amorphous
solid. Data for 22a: [a]D24 -8.1 (c 0.7, CHCl3); IR (KBr disk, cm-1)
(br d, 1H, J = 2.7), 4.63 (ddd, 1H, J = 8.2, 8.0, 8.0), 4.21 (d, 1H,
J = 7.1), 4.09–4.21 (m, 2H), 3.18 (ddd, 1H, J = 11.2, 11.0, 2.7),
3.06 (dd, 1H, J = 15.3, 8.0), 2.96 (dd, 1H, J = 15.6, 9.4), 2.79 (dd,
1H, J = 11.3, 3.6), 2.32–2.49 (m, 2H), 2.18–2.30 (m, 4H), 1.24 (t,
3H, J = 7.1), 1.04 (s, 9H), 0.83 (d, 3H, J = 6.9), 0.31 (s, 3H), 0.22 (s,
3H), 0.05 (d, 3H, J = 6.9); 13C NMR (100 MHz, CDCl3) d 167.0,
147.9, 144.9, 140.5, 140.0, 137.3, 135.8, 135.2, 129.9, 129.8, 128.4,
126.7, 125.9, 124.6, 123.6, 122.8, 122.2, 122.1, 121.2, 113.5, 60.5,
60.4, 55.4, 42.2, 42.1, 27.6, 26.4, 26.1, 25.6, 23.1, 21.4, 18.0, 14.2,
-3.6, -4.0; ESI HRMS m/z calcd for C41H52N2O5S1Si1 (M+Na)+
735.3264, found 735.3232.
3-{(2S)-1-[(1S,2R)-cis-1-(t-butyldimethylsilyloxy)-7-isopropy-
lindan-1-yl]-2-(N-p-toluenesulfonylindol-3-yl)-1,2,5,6-tetrahydro-
pyridin-4-yl}pentan-3-ol (24). To a solution of 23 (53 mg,
0.074 mmol) in ether (2.1 ml) was slowly added ethyl magnesium
bromide (1.2 ml, 1.19 mmol, 1.0 M in ether) at 0 ◦C. After the
mixture was stirred for 3 h, H2O and saturated aqueous NH4Cl
solution were carefully added, and the resulting mixture was
extracted with ethyl acetate. The organic layers were combined,
washed with brine, dried over MgSO4, filtered and concentrated
in vacuo to give the crude products. Column chromatography on
silica gel (from 6.3% to 12% ethyl acetate in hexane) gave the
product 24 (37 mg, 69%) as a yellow amorphous solid: [a]2D5 -80.3
(c 1.0, CHCl3); IR (KBr disk, cm-1) 2960, 2930, 2855, 1375, 1174,
1099,; 1H NMR (400 MHz, CDCl3) d 8.00 (d, 1H, J = 8.5), 7.76
(d, 2H, J = 8.2), 7.69 (d, 1H, J = 7.6), 7.55 (s, 1H), 7.29 (dd, 1H,
J = 7.8, 7.8), 7.12–7.18 (m, 4H), 6.89–6.96 (m, 2H), 5.71–5.75 (br
s, 1H), 5.49–5.52 (m, 1H), 4.65 (dd, 1H, J = 16.0, 8.2), 4.22 (d,
1H, J = 7.1), 3.25 (ddd, 1H, J = 11.0, 11.0, 2.7), 3.06 (dd, 1H, J =
15.6, 8.0), 2.96 (dd, 1H, J = 15.1, 8.0), 2.72 (dd, 1H, J = 15.1, 9.2),
2.48–2.60 (br m, 1H), 2.26 (s, 1H), 1.82–2.10 (m, 1H), 1.80 (d, 1H,
J = 16.0), 1.44–1.63 (m, 4H), 1.03 (s, 9H), 0.81–0.89 (m, 6H), 0.76
(t, 3H, J = 7.6), 0.30 (s, 1H), 0.21 (s, 1H), 0.03–0.13 (br m, 3H);
13C NMR (100 MHz, CDCl3) d 147.9, 144.8, 140.6, 139.4, 137.9,
135.9, 135.3, 130.1, 129.8, 129.7, 128.2, 126.7, 125.4, 124.6, 124.4,
123.8, 123.5, 122.3, 121.1, 113.5, 77.5, 69.7, 55.2, 42.7, 42.2, 32.1,
31.2, 27.6, 27.3, 26.1, 26.0, 25.6, 23.1, 22.8, 21.4, 17.9, 7.8, 7.6
–4.0, -4.7; ESI HRMS m/z calcd for C43H58N2O4S1Si1 (M+Na)+
749.3784, found 749.3752.
1
2959, 2934, 2876, 1724, 1370, 1177, 749; H NMR (400 MHz,
CDCl3) d 7.97 (d, 1H, J = 8.2 Hz), 7.70–7.75 (m, 3H), 7.54 (s,
1H), 7.29 (dd, 1H, J = 8.2, 7.3 Hz), 7.16–7.23 (m, 3H), 4.39 (d,
1H, J = 9.4 Hz), 4.11–4.25 (m, 2H), 3.13 (ddd, 1H, J = 11.9,
10.1, 3.0 Hz), 2.99 (dd, 1H, J = 8.9, 4.4 Hz), 2.93 (ddd, 1H, J =
11.9, 3.9, 3.9 Hz), 2.32 (s, 1H), 1.78–2.00 (m, 3H), 1.02–1.33 (m,
5H), 0.69 (t, 3H, J = 7.3 Hz); 13C NMR (100 MHz, CDCl3) d
174.3, 144.7, 135.3, 135.2, 130.3, 130.0, 126.7, 124.6, 123.8, 123.0,
120.7, 113.7, 60.4, 60.0, 53.6, 45.2, 42.5, 40.3, 28.6, 22.5, 21.5,
21.0, 14.3, 14.2, 11.6; ESI HRMS m/z calcd for C25H30N2O4S1
(M+H)+ 455.2005, found 455.1996. Data for 22b: [a]2D2 -29.1 (c
1.1, CHCl3); IR (KBr disk, cm-1) 2936, 2812, 1728, 1371, 1175,
749; 1H NMR (400 MHz, CDCl3) d 7.97 (d, 1H, J = 8.2 Hz), 7.79
(d, 1H, J = 7.8 Hz), 7.72 (d, 2H, J = 8.4 Hz), 7.52 (s, 1H), 7.30
(dd, 1H, J = 7.3, 7.1 Hz), 7.22 (dd, 1H, J = 8.2, 7.3 Hz), 7.18 (d,
2H, J = 8.5 Hz), 4.08–4.29 (m, 2H), 3.67 (d, 1H, J = 10.3 Hz),
3.17 (ddd, 1H, J = 11.7, 3.4, 2.7 Hz), 2.76 (ddd, 1H, J = 11.5,
11.2, 3.4 Hz), 2.45 (ddd, 1H, J = 11.2, 11.2, 4.9 Hz), 2.11 (dddd,
1H, J = 10.8, 10.8, 4.1, 4.1 Hz), 1.82–1.96 (m, 2H), 1.26 (t, 3H,
J = 7.3 Hz), 1.11–1.21 (m, 1H), 0.97–1.09 (m, 1H), 0.59 (t, 3H,
J = 7.6 Hz),; 13C NMR (100 MHz, CDCl3) d 175.1, 144.8, 135.4,
135.1, 130.0, 126.7, 124.7, 124.3, 123.9, 123.0, 121.0, 113.7; ESI
HRMS m/z calcd for C25H30N2O4S1 (M+H)+ 455.2005, found
455.1986.
Ethyl (2S)-1-[(1S,2R)-cis-2-(t-butyldimethylsilyloxyl)-7-isopro-
pylindan-1-yl]-2-(N-p-toluenesulfonylindol-3-yl)-1,2,5,6-tetrahy-
dropyridine-4-carboxylate (23). To a solution of 20 (251 mg,
0.419 mmol) in dimethylformamide (4.0 ml) were added tri-
ethylamine (0.6 ml, 8.23 mmol) and t-butyldimethylchlorosilane
(126 mg, 0.84 mmol) and 4,4-dimethylamino-4-pyridine (26 mg,
0.21 mmol) at 0 ◦C. After the mixture was stirred at room
temperatue for 20 h, a saturated aqueous NaHCO3 solution was
added, and the resulting mixture was extracted with ethyl acetate.
The organic layers were combined, washed twice with water for
twice and with brine, dried over MgSO4, filtered and concentrated
in vacuo to give the crude products. Column chromatography on
silica gel (from 6.3% to 33% ethyl acetate in hexane) gave the
product 23 (101 mg, 34%) as a yellow amorphous solid and recover
of the starting material 20 (98 mg): [a]2D4 -76.1 (c 0.7, CHCl3); IR
Ethyl (2S,3S,4S)-(-)-3-ethyl-N-methyl-2-(N-p-toluenesulfonyl-
indol-3-yl)-piperidine-4-carboxylate (31a) and Ethyl (2S,3S,4R)-
(-)-3-ethyl-N-methyl-2-(N-p-toluenesulfonylindol-3-yl)-piperidine-
4-carboxylate (31b). To a solution of 22a, 22b (448 mg,
0.985 mmol, mixture of diastereomers) and 37% aqueous
formaldehyde (400 ml, 4.93 mmol) in acetonitrile (9.8 ml) was
added sodium cyanoborohydride (124 mg,1.97 mmol) at room
temperature. After the mixture was stirred at this temperature
for 30 min, a saturated aqueous NaHCO3 solution was added,
and the resulting mixture was extracted with chloroform. The
organic layers were combined, dried over MgSO4, filtered and
concentrated in vacuo to give the crude products. Column
chromatography on silica gel (from 0% to 1.0% methanol in
chloroform) gave the alcohol product 31a (111 mg, 24%) as a
yellow amorphous solid and 31b (334 mg, 72%) as a yellow
amorphous solid. Data for 31a: [a]2D2 -30.0 (c 1.1, CHCl3); IR
(KBr disk, cm-1) 2939, 2878, 2793, 1727, 1447, 1372, 1177, 749;
1H NMR (400 MHz, CDCl3) d 7.98 (d, 1H, J = 8.3 Hz), 7.87
(d, 1H, J = 7.3 Hz), 7.69 (d, 2H, J = 8.5 Hz), 7.47 (s, 1H), 7.27
1
(KBr disk, cm-1) 2930, 2856, 1713, 1377, 1257, 1097; H NMR
(400 MHz, CDCl3) d 8.00 (d, 1H, J = 8.2), 7.76 (d, 2H, J = 8.2),
7.59 (s, 1H), 7.54 (d, 1H, J = 7.8), 7.31 (dd, 1H, J = 7.3, 7.3), 7.12–
7.22 (m, 4H), 6.90–6.96 (m, 2H), 6.72–6.75 (br m, 1H), 5.80–5.85
This journal is
The Royal Society of Chemistry 2011
Org. Biomol. Chem., 2011, 9, 257–264 | 261
©